P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma
- PMID: 9743295
- PMCID: PMC2062957
- DOI: 10.1038/bjc.1998.573
P-glycoprotein and metallothionein expression and resistance to chemotherapy in osteosarcoma
Abstract
The expression of the drug resistance (DR) mediators P-glycoprotein (P-gp) and the metallothioneins (MT) was assessed immunohistochemically in biopsy material from patients with high-grade malignant osteosarcoma (OS). No significant difference was found in survival rate between expressors of both P-gp and MT and non-expressors. Thus, it was concluded that lack of expression of these two drug resistance-related proteins does not appear to confer any advantage in terms of patient survival in osteosarcoma.
Similar articles
-
Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis.Cancer. 1997 Jun 15;79(12):2336-44. doi: 10.1002/(sici)1097-0142(19970615)79:12<2336::aid-cncr7>3.0.co;2-j. Cancer. 1997. PMID: 9191521
-
The co-expression of p53 protein and P-glycoprotein is correlated to a poor prognosis in osteosarcoma.Int Orthop. 2001;24(6):307-10. doi: 10.1007/s002640000196. Int Orthop. 2001. PMID: 11294418 Free PMC article.
-
Doxorubicin induced expression of P-glycoprotein in a canine osteosarcoma cell line.Cancer Lett. 1998 Apr 24;126(2):187-92. doi: 10.1016/s0304-3835(98)00004-4. Cancer Lett. 1998. PMID: 9585065
-
Proteins expressed in osteosarcoma and serum levels as prognostic factors.Int J Biochem Cell Biol. 2001 Jan;33(1):11-7. doi: 10.1016/s1357-2725(00)00066-2. Int J Biochem Cell Biol. 2001. PMID: 11167128 Review.
-
Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.Oncotarget. 2016 Dec 13;7(50):83502-83513. doi: 10.18632/oncotarget.13148. Oncotarget. 2016. PMID: 27835872 Free PMC article. Review.
Cited by
-
Zinc chelation: a metallothionein 2A's mechanism of action involved in osteosarcoma cell death and chemotherapy resistance.Cell Death Dis. 2013 Oct 24;4(10):e874. doi: 10.1038/cddis.2013.405. Cell Death Dis. 2013. PMID: 24157868 Free PMC article.
-
Functional imaging of multidrug resistance in an orthotopic model of osteosarcoma using 99mTc-sestamibi.Eur J Nucl Med Mol Imaging. 2007 Nov;34(11):1793-803. doi: 10.1007/s00259-007-0480-8. Epub 2007 Jun 1. Eur J Nucl Med Mol Imaging. 2007. PMID: 17541583
-
Metallothionein expression in hepatocellular carcinoma.World J Gastroenterol. 2002 Aug;8(4):650-3. doi: 10.3748/wjg.v8.i4.650. World J Gastroenterol. 2002. PMID: 12174372 Free PMC article.
-
Lipid-functionalized dextran nanosystems to overcome multidrug resistance in cancer: a pilot study.Clin Orthop Relat Res. 2013 Mar;471(3):915-25. doi: 10.1007/s11999-012-2610-2. Clin Orthop Relat Res. 2013. PMID: 23011844 Free PMC article.
-
Immunohistochemical Estimates of Angiogenesis, Proliferative Activity, p53 Expression, and Multiple Drug Resistance Have No Prognostic Impact in Osteosarcoma: A Comparative Clinicopathological Investigation.Sarcoma. 2008;2008:874075. doi: 10.1155/2008/874075. Epub 2009 Feb 25. Sarcoma. 2008. PMID: 19266050 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous